NCT01715311View on ClinicalTrials.gov

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Indacaterol

Indacaterol once daily via single-dose dry powder inhaler

DRUG

Placebo to tiotropium

Placebo to tiotropium capsules for inhalation once daily

DRUG

Tiotropium

Tiotropium capsules for inhalation once daily

DRUG

Placebo to indacaterol

Placebo to indacaterol capsules for inhalation once daily

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY